The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial

Crash-2 Collaborators - The Lancet, 2011 - Elsevier
BACKGROUND: The aim of the CRASH-2 trial was to assess the effects of early
administration of tranexamic acid on death, vascular occlusive events, and blood transfusion …
被引用次数：1416 相关文章

[引用][C] The importance of early treatment with tranexamic acid in bleeding trauma patients: An exploratory analysis of the CRASH-2 randomised controlled trial

F Olldashi, M Kerçi, T Zhurda, K Ruçi, A Banushi… - The …, 2011 - investigacion.usc.gal
Background The aim of the CRASH-2 trial was to assess the effects of early administration of
tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma …

The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial

I Roberts, H Shakur, A Afolabi, K Brohi, T Coats… - 2011 - pubmed.ncbi.nlm.nih.gov
Background The aim of the CRASH-2 trial was to assess the effects of early administration of
tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma …

The importance of early treatment with tranexamic acid in bleeding trauma patients: An exploratory analysis of the CRASH-2 randomised controlled trial

F Olldashi, M Kerçi, T Zhurda, K Ruçi, A Banushi… - The …, 2011 - scholar.unair.ac.id
Background The aim of the CRASH-2 trial was to assess the effects of early administration of
tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma …
[HTML] mq.edu.au

[HTML][HTML] The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial

F Olldashi, M Kerçi, T Zhurda, K Ruçi… - The …, 2011 - researchers.mq.edu.au
Background The aim of the CRASH-2 trial was to assess the effects of early administration of
tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma …

The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial.

I Roberts, H Shakur, A Afolabi, K Brohi… - Lancet (London …, 2011 - europepmc.org
Background The aim of the CRASH-2 trial was to assess the effects of early administration of
tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma …

The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial.

I Roberts, H Shakur, A Afolabi, K Brohi, T Coats… - …, 2011 - researchonline.lshtm.ac.uk
BACKGROUND: The aim of the CRASH-2 trial was to assess the effects of early
administration of tranexamic acid on death, vascular occlusive events, and blood transfusion …

[引用][C] The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomized controlledtrial

CRASH-2 collaborators - Lancet, 2011 - cir.nii.ac.jp
The importance of early treatment with tranexamic acid in bleeding trauma patients : an
exploratory analysis of the CRASH-2 randomized controlledtrial | CiNii Research CiNii 国立 …

The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial

I Roberts, H Shakur, A Afolabi, K Brohi, T Coats… - The …, 2011 - research.ed.ac.uk
The aim of the CRASH-2 trial was to assess the effects of early administration of tranexamic
acid on death, vascular occlusive events, and blood transfusion in trauma patients with …

The importance of early treatment with tranexamic acid in bleeding trauma patients: An exploratory analysis of the CRASH-2 randomised controlled trial

F Olldashi, M Kerçi, T Zhurda, K Ruçi, A Banushi… - The Lancet, 2011 - scholar.ui.ac.id
Background The aim of the CRASH-2 trial was to assess the effects of early administration of
tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma …